Area of research
Cancer Research · Hematology
Research interest
Research interests include Protease and Inhibitor Mechanisms, Blood Coagulation and Thrombosis Mechanisms, Signaling Pathways in Disease, and Cell Adhesion Molecules Research.
Suppression of Heart Failure With PAR1 Pepducin Technology in a Pressure Overload Model in Mice.
PAR1 (Protease-Activated Receptor 1) Pepducin Therapy Targeting Myocardial Necrosis in Coronary Artery Disease and Acute Coronary Syndrome Patients Undergoing Cardiac Catheterization: A Randomized, Placebo-Controlled, Phase 2 Study.
Enhanced potency of prasugrel on protease-activated receptors following bivalirudin treatment for PCI as compared to clopidogrel